ArticleCureus2026
Development and Validation of a Standardized Palpebral Conjunctival Redness Scale.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to develop and validate a standardized palpebral conjunctival redness (PCR) scale for clinical assessment of ocular inflammation, addressing the distinct vascular anatomy and immune characteristics of the palpebral conjunctiva compared to the bulbar conjunctiva.
methodsA study was conducted using digital image manipulation to create a 10-point PCR grading scale (10-100 in increments of 10). The scale was developed through Adobe Photoshop modification of high-resolution ocular photographs and validated by trained ophthalmic professionals. A total of 24 eyes from 12 patients were assessed using both the newly developed PCR scale and the established Schulze bulbar conjunctival redness (BCR) scale. Statistical analysis included Cronbach's alpha for internal consistency, intraclass correlation coefficients (ICC) for inter-rater reliability, paired t-tests for comparison between PCR and BCR scores, and Pearson's correlation coefficient to assess the relationship between the two measures.
resultsThe PCR scale demonstrated excellent inter-rater reliability with an ICC of 0.773 (95% CI: 0.537-0.896) and strong internal consistency with a Cronbach's alpha of 0.880. Individual components showed robust reliability ranging from 0.842 to 0.891. Mean PCR scores were significantly higher than BCR scores by 15.90 units (p<0.0001), with a moderate correlation coefficient of 0.45 between the two measures. The combined PCR and BCR assessment achieved an ICC of 0.852 (95% CI: 0.780-0.902).
conclusionThis study successfully established a reliable and clinically applicable PCR grading scale that addresses the unique anatomical and immunological characteristics of the palpebral conjunctiva. The moderate correlation between PCR and BCR measurements supports the necessity of independent assessment tools for different conjunctival regions. The PCR scale complements existing BCR assessments and provides enhanced diagnostic sensitivity for conditions affecting the eyelid margins and inner conjunctival surfaces. Further validation in larger, more diverse patient populations is recommended before widespread clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.